Literature DB >> 2536101

Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.

D A Leib1, D M Coen, C L Bogard, K A Hicks, D R Yager, D M Knipe, K L Tyler, P A Schaffer.   

Abstract

Using nonsense and deletion mutants of herpes simplex virus type 1, we investigated the roles of three immediate-early proteins (ICP4, ICP27 and ICP0) in the establishment and reactivation of ganglionic latency in a mouse ocular model. DNA hybridization, superinfection-rescue, and cocultivation techniques provided quantitative data that distinguished between the failure of a virus to establish latency in the ganglion and its failure to reactivate. Null mutants with lesions in the genes for ICP4 and ICP27 did not replicate in the eye or in ganglia and failed to establish reactivatable latent infections. Three ICP0 deletion mutants which could replicate in the eye and ganglia varied in their ability to establish and reactivate from the latent state, demonstrating that ICP0 plays a role both in the establishment and the reactivation of latency. The use of viral mutants and a variety of stage-specific assays allowed us to better define the stages in the establishment and reactivation of herpes simplex virus type 1 latency.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536101      PMCID: PMC247748     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons.

Authors:  J G Stevens; E K Wagner; G B Devi-Rao; M L Cook; L T Feldman
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

2.  Three trans-acting regulatory proteins of herpes simplex virus modulate immediate-early gene expression in a pathway involving positive and negative feedback regulation.

Authors:  P O'Hare; G S Hayward
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

3.  Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4.

Authors:  N A DeLuca; P A Schaffer
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

4.  Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture.

Authors:  W R Sacks; P A Schaffer
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  Regulation of the herpes simplex virus type 1 late (gamma 2) glycoprotein C gene: sequences between base pairs -34 to +29 control transient expression and responsiveness to transactivation by the products of the immediate early (alpha) 4 and 0 genes.

Authors:  M Shapira; F L Homa; J C Glorioso; M Levine
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

6.  Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110.

Authors:  N D Stow; E C Stow
Journal:  J Gen Virol       Date:  1986-12       Impact factor: 3.891

7.  The products of herpes simplex virus type 1 (HSV-1) immediate early genes 1, 2 and 3 can activate HSV-1 gene expression in trans.

Authors:  R D Everett
Journal:  J Gen Virol       Date:  1986-11       Impact factor: 3.891

8.  Characterization of the IE110 gene of herpes simplex virus type 1.

Authors:  L J Perry; F J Rixon; R D Everett; M C Frame; D J McGeoch
Journal:  J Gen Virol       Date:  1986-11       Impact factor: 3.891

9.  Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS.

Authors:  R L Thompson; M L Cook; G B Devi-Rao; E K Wagner; J G Stevens
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

10.  Homology between murine and human cellular DNA sequences and the terminal repetition of the S component of herpes simplex virus type 1 DNA.

Authors:  A Puga; E M Cantin; A L Notkins
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

View more
  220 in total

1.  Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0.

Authors:  W E Hobbs; N A DeLuca
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system.

Authors:  J A Palmer; R H Branston; C E Lilley; M J Robinson; F Groutsi; J Smith; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival.

Authors:  W E Hobbs; D E Brough; I Kovesdi; N A DeLuca
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Infection of human NT2 cells and differentiated NT-neurons with herpes simplex virus and replication-incompetent herpes simplex virus vectors.

Authors:  J P Weir
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

5.  Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus.

Authors:  Shun-Hua Chen; Lily Yeh Lee; David A Garber; Priscilla A Schaffer; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 renders expression of the immediate-early genes almost entirely dependent on ICP0.

Authors:  K L Mossman; J R Smiley
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse.

Authors:  D Y Ho; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 8.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

9.  Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins.

Authors:  J Parkinson; R D Everett
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

10.  Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA.

Authors:  W Z Cai; P A Schaffer
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.